Ledley’s survey and article also shaped the National Institutes of Health’s first major effort to encourage biomedical researchers to use computers. This effort began shortly after the Soviet launch of Sputnik in October 1957—in reaction to Sputnik, the U.S. Congress sought means boost U.S. scientific and technological productivity. Beginning in 1960, Congress allocated roughly $40 million to the NIH for the purpose of stimulating computer use in biomedical research. Ledley’s survey recommendations, particularly his call for biomedical workers to train extensively in mathematics and engineering, served as a guide for the NIH effort, which was carried out by the NIH’s Advisory Committee on Computers in Research (ACCR). The ACCR was led from 1960 to 1964 by Ledley’s collaborator, Lee Lusted. During those years, the committee established several major biomedical computing centers around the USA and sponsored the development of the LINC. The ACCR’s successor, the Computers in Research Study Section, was headed by Homer Warner, one of the first research physicians to employ Ledley and Lusted’s techniques in a clinical setting.
Following his survey work for the NAS-NRC and the publication of his and Lusted’s articles in Science, Ledley sought federal government and university support his efforts to development computers and computer programs for use by biomedical researchers. With the support of the NAS-NRC, Ledley chartered in 1960 the National Biomedical Research Foundation (NBRF), a nonprofit organization, initially based in an NAS-NRC-owned building near Dupont Circle, Washington, D.C.
The NBRF’s earliest area of emphasis was developing optical pattern recognition technology. Working with Wilson in 1960 and 1961, Ledley built the Automatic Device for Antibiotic Determination (ADAD), a computerized light-measuring device that tested for efficacy of antibiotic drugs by measuring transparency in petri dish cultures. Areas that were transparent were likely areas where the antibiotics had killed the bacterial populations; areas that were opaque likely areas where the bacteria were still alive. The NBRF sold several ADAD units to the Food and Drug Administration, and to large pharmaceutical companies.